Otvos James D. 4
4 · LIPOSCIENCE INC · Filed Mar 25, 2013
Insider Transaction Report
Form 4
LIPOSCIENCE INCLPDX
Otvos James D.
EVP, Chief Scientific Officer
Transactions
- Award
Common Stock
2013-03-01$9.65/sh+3,151$30,407→ 476,041 total - Award
Stock Option (right to buy)
2013-03-01+18,905→ 18,905 totalExercise: $9.65Exp: 2023-02-28→ Common Stock (18,905 underlying)
Holdings
- 180,167(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Represents shares issuable upon the vesting of restricted stock units granted to the reporting person on March 1, 2013. The restricted stock units vest 100% on March 1, 2016, subject to the reporting person's continuous service with the issuer as of the vesting date.
- [F2]The option vests over a period of four years, with 1/16 of the shares underlying the option vesting on a quarterly basis, starting June 1, 2013, subject to the reporting person's continuous service with the issuer as of the applicable vesting date.